Related Experiment Videos
Cemented polyethylene cups in patients younger than 40 years
Daniël C J de Kam1, Jean W M Gardeniers, Jan C M Hendriks
1Department of Orthopaedic Surgery 357, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
This study evaluated the use of cemented acetabular cups in patients younger than 40 years. A total of 175 cemented cups were implanted in 130 patients, with no loss to follow-up. The average follow-up was 8.1 years. Of the 175 cups, 12% required revision, with aseptic loosening and infection being the most common reasons. Bone impaction grafting was used in 48% of cases and showed better survival rates for aseptic loosening compared to cups without grafting. The authors conclude that cemented cups in young patients have acceptable midterm survival and recommend bone impaction grafting in cases of acetabular bone defects.
Area of Science:
- Orthopedic surgery outcomes research
- Joint replacement implant longevity
- Surgical reconstruction techniques
Background:
Long-term success of hip implants in young patients remains uncertain. Prior research has shown that uncemented cups may not always provide durable fixation in younger populations. This gap motivated the exploration of alternative implant fixation methods. No prior work had resolved the optimal strategy for acetabular reconstruction in young adults. Established knowledge shows that cemented implants have been used historically for stability. However, concerns about cemented cup longevity persist in younger patients. The need for reliable implant fixation in this age group remains unmet. This uncertainty drove the investigation into cemented cup survival rates.
Purpose Of The Study:
The aim was to assess the midterm survival of cemented acetabular cups in patients under 40 years old. The specific problem is the lack of consensus on implant fixation methods for young patients. Motivation comes from observed challenges with uncemented cups in this demographic. The study sought to determine if cemented cups offer acceptable survival rates. It also aimed to evaluate the impact of bone impaction grafting on outcomes. The focus was on revision rates and causes in this age group. The goal was to provide evidence-based guidance for implant selection. This study addresses a clinical need for durable solutions in young patients.
Main Methods:
A prospective cohort study was conducted with 130 patients and 175 cemented cups. Patients were under 40 years old at the time of surgery. Follow-up data was collected with no loss to follow-up. The mean age at surgery was 31 years, ranging from 16 to 39. Bone impaction grafting was used in 48% of cases. The minimum follow-up duration was 2 years, averaging 8.1 years. Revision reasons were categorized and recorded. The study evaluated survival rates using standard endpoints.
Main Results:
Of 175 cups, 21 (12%) required revision at an average of 8.1 years. Infection accounted for 8 revisions, with one early and seven late cases. Recurrent dislocations led to two revisions, and traumatic loosening to one. Aseptic loosening was the cause in 10 revisions. The 10-year survival rate with any revision as the endpoint was 85%. For aseptic loosening alone, survival was 92%. Cups with impaction grafting had 95% survival for aseptic loosening. Cups without grafting had 90% survival for the same endpoint.
Conclusions:
The authors propose that cemented cups in young patients have acceptable midterm survival. They suggest that cemented cups remain a viable option despite age-related concerns. The study supports the use of cemented cups in primary THA for this age group. In cases of acetabular bone defects, the authors recommend bone impaction grafting. The data shows improved survival with grafting for aseptic loosening. The findings align with the authors' prior clinical experience. The study does not claim cemented cups are superior in all cases. The authors state that their conclusions are based on observed outcomes.
Frequently Asked Questions
The 10-year survival rate with any revision was 85%, and with aseptic loosening as the endpoint, it was 92%.
Cups with grafting had 95% survival for aseptic loosening versus 90% without grafting.
The authors propose that grafting improves survival rates in cases of bone stock defects.
The average follow-up was 8.1 years, with a range of 2.0 to 18.5 years.
Infection (8 cases) and aseptic loosening (10 cases) were the most common reasons for revision.
The authors suggest that cemented cups in young patients have acceptable midterm survival and recommend grafting in bone defects.